These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12723850)

  • 1. A study of treatment outcomes from atypical antipsychotic medications in the Virginia public system of community care.
    Ziegler DM; Peachey TJ
    Community Ment Health J; 2003 Apr; 39(2):169-82. PubMed ID: 12723850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antipsychotic medication on psychiatric service utilization and cost.
    Rothbard A; Murrin MR; Jordan N; Kuno E; McFarland BH; Stroup TS; Morrissey JP; Stiles PG; Boothroyd RA; Merwin E; Shern DL
    J Ment Health Policy Econ; 2005 Jun; 8(2):83-93. PubMed ID: 15998980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of switching from typical to atypical antipsychotic medications: a longitudinal study in a community-based setting.
    Cook PE; Goldberg JO; Van Lieshout RJ
    Can J Psychiatry; 2002 Nov; 47(9):870-4. PubMed ID: 12500758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of healthcare utilization patterns and adherence in patients receiving typical and atypical antipsychotic medications.
    Al-Zakwani IS; Barron JJ; Bullano MF; Arcona S; Drury CJ; Cockerham TR
    Curr Med Res Opin; 2003; 19(7):619-26. PubMed ID: 14606985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of clozapine therapy for severe psychosis.
    Ghaemi SN; Ziegler DM; Peachey TJ; Goodwin FK
    Psychiatr Serv; 1998 Jun; 49(6):829-31. PubMed ID: 9634167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the utility of atypical antipsychotic medication in adults with mild mental retardation and comorbid psychiatric disorders.
    Shedlack KJ; Hennen J; Magee C; Cheron DM
    J Clin Psychiatry; 2005 Jan; 66(1):52-62. PubMed ID: 15669889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of community mental health services on hospitalization rates in Virginia.
    Wanchek TN; McGarvey EL; Leon-Verdin M; Bonnie RJ
    Psychiatr Serv; 2011 Feb; 62(2):194-9. PubMed ID: 21285098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of patients' refusal of antipsychotic medication under a physician discretion review procedure.
    Kasper JA; Hoge SK; Feucht-Haviar T; Cortina J; Cohen B
    Am J Psychiatry; 1997 Apr; 154(4):483-9. PubMed ID: 9090334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community treatment orders: relationship to clinical care, medication compliance, behavioural disturbance and readmission.
    Vaughan K; McConaghy N; Wolf C; Myhr C; Black T
    Aust N Z J Psychiatry; 2000 Oct; 34(5):801-8. PubMed ID: 11037366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors.
    Sankaranarayanan J; Puumala SE
    Clin Ther; 2007 Apr; 29(4):723-41. PubMed ID: 17617297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From clinical trials to real-world practice: use of atypical antipsychotic medication nationally in the Department of Veterans Affairs.
    Rosenheck R; Leslie D; Sernyak M
    Med Care; 2001 Mar; 39(3):302-8. PubMed ID: 11242324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and economic impact of newer versus older antipsychotic medications in a community mental health center.
    Galvin PM; Knezek LD; Rush AJ; Toprac MG; Johnson B
    Clin Ther; 1999 Jun; 21(6):1105-16. PubMed ID: 10440630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community Mental Health Center Integrated Care Outcomes.
    Wells R; Kite B; Breckenridge E; Sunbury T
    Psychiatr Q; 2018 Dec; 89(4):969-982. PubMed ID: 30090994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of antipsychotic medications in treating schizophrenia among different financing and delivery systems.
    Bloom JR; Cheng JS; Hu TW; Kang SH; Wallace N
    J Ment Health Policy Econ; 2003 Dec; 6(4):163-71. PubMed ID: 14713723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and characteristics of emergency departments visits by US adults with psychiatric disorder and antipsychotic mention from 2000 to 2004.
    Sankaranarayanan J; Puumala SE
    Curr Med Res Opin; 2007 Jun; 23(6):1375-85. PubMed ID: 17594776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients.
    Aparasu RR; Jano E; Johnson ML; Chen H
    Am J Geriatr Pharmacother; 2008 Oct; 6(4):198-204. PubMed ID: 19028375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric hospital utilization in patients treated with clozapine for up to 4.5 years in a state mental health care system.
    Reid WH; Mason M
    J Clin Psychiatry; 1998 Apr; 59(4):189-94. PubMed ID: 9590670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A five year follow-up study of the use of clozapine in community practice.
    Drew LR; Griffiths KM; Hodgson DM
    Aust N Z J Psychiatry; 2002 Dec; 36(6):780-6. PubMed ID: 12406120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and economic outcomes associated with olanzapine for the treatment of psychotic symptoms in a county mental health population.
    Del Paggio D; Finley PR; Cavano JM
    Clin Ther; 2002 May; 24(5):803-17. PubMed ID: 12075948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.